Skip to main content
OpenTrials

Clinical trial condition

Non Small Cell Lung Cancer

Explore clinical trials studying Non Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

654 public trials 176 recruiting studies
Refine in advanced search Browse all conditions

Non Small Cell Lung Cancer trial results

Active, Not Recruiting

Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer

NCT03907852

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +38 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • University of Miami Sylvester Cancer Center Miami, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • National Cancer Institute Bethesda, Maryland, United States
View Trial Details
Active, Not Recruiting

CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC

NCT04495153

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UConn Health Farmington, Connecticut, United States
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • University of Chicago Chicago, Illinois, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

NCT05864144

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +101 more
Locations
  • UCLA Hematology/Oncology Los Angeles, California, United States
  • University of Colorado Cancer Center - Anschutz Medical Aurora, Colorado, United States
  • Norton Healthcare Louisville, Kentucky, United States
  • Henry Ford Cancer Detroit, Michigan, United States
View Trial Details
Active, Not Recruiting

Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC

NCT03970746

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Grand Hôpital de Charleroi Charleroi, Belgium
  • Jessa Ziekenhuis Hasselt, Belgium
  • AZ Groeninge Kortrijk, Belgium
  • University Hospitals KU Leuven Leuven, Belgium
View all 16 locations
View Trial Details
Active, Not Recruiting

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

NCT05704985

Conditions
Bronchial Neoplasms, Cancer, Carcinoma, Bronchogenic, +42 more
Locations
  • City of Hope Duarte, California, United States
  • Northwell Health Manhasset, New York, United States
  • OU Health Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Mary Crowley Cancer Research Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

NCT04140526

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +94 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University of California at Davis Davis, California, United States
  • The Oncology Institute of Hope and Innovation Downey, California, United States
  • City of Hope Cancer Center Duarte, California, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression

NCT05736731

Conditions
Bronchial Neoplasms, CRC, Cancer, +38 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details

Related conditions